Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 6 of 6 for “"Anti-VEGF agent"”.

  1. Pazopanib Loaded PLGA Nanoparticles for the Treatment of Age-related Macular Degeneration

    … on vascular endothelial growth factor receptor (VEGFR). An intraocular injection to posterior segment of eye of anti-VEGF agent at present represents the cornerstone of therapies for AMD. However, challenges in targeting and delivering drug to eye’s posterior segment well as difficulties arising …

    usf Repository record for Pazopanib Loaded PLGA Nanoparticles for the Treatment of Age-related Macular Degeneration (opens in a new tab)

  2. Biomarkers of anti-angiogenic therapy in breast cancer

    <p>The hunt for biomarkers for anti-VEGF agent bevacizumab is ongoing since last decade with no success. Identifying robust biomarkers for stratifying patients and for monitoring response is important for the future use of bevacizumab in breast cancer. Dynamic contrast-enhanced magnetic resonance …

    oxford Repository record for Biomarkers of anti-angiogenic therapy in breast cancer (opens in a new tab)

  3. Ο ρόλος των αντινεοαγγειακών παραγόντων στο διαβητικό οίδημα της ωχράς

    … diabetic retinopathy has been the advent of the anti-VEGF therapy ranibizumab (Lucentis, Genentech) for diabetic macular edema (DME) The most significant effect that the RISE and RIDE data have had is that patients with center-involving DME have a good chance of substantially improving their …

    greece Repository record for Ο ρόλος των αντινεοαγγειακών παραγόντων στο διαβητικό οίδημα της ωχράς (opens in a new tab)

  4. Safety, effectiveness, and cost among Texas Medicaid patients with Diabetic Macular Edema (DME) or Age-Related Macular Degeneration (AMD)

    … careful consideration. However, as the use of anti-VEGF agent increases, further research should be conducted to determine if any changes in cardiovascular adverse events occur.

    texas Repository record for Safety, effectiveness, and cost among Texas Medicaid patients with Diabetic Macular Edema (DME) or Age-Related Macular Degeneration (AMD) (opens in a new tab)

  5. Use of Echogenic Immunoliposomes For Delivery of Both Drug and Stem Cells For Inhibition of Atheroma Progression

    … progression. Vascular endothelial growth factor (VEGF) is a signal protein that induces vasculogenesis and angiogenesis. VEGF functionally induces migration and proliferation of endothelial cells and increases intracellular vascular permeability. VEGF activates angiogenic transduction factors …

    uthsc Repository record for Use of Echogenic Immunoliposomes For Delivery of Both Drug and Stem Cells For Inhibition of Atheroma Progression (opens in a new tab)

  6. Honokiol Loaded MPEG-PCL Micelles for the Treatment of Age-Related Macular Degeneration

    … involve multiple intraocular injections of Anti – VEGF agents into the vitreous of eye. In addition to the issues of drug localization and targeted delivery, the need to frequently inject drug into the eye raise patient compliance issues. These challenges call for sustained drug delivery …

    usf Repository record for Honokiol Loaded MPEG-PCL Micelles for the Treatment of Age-Related Macular Degeneration (opens in a new tab)